###begin article-title 0
Cytokine Production by Whole Blood Cells: Relationship to Interleukin Gene Polymorphism and Bone Mass
###end article-title 0
###begin p 1
###xml 584 588 573 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-889</sup>
###xml 614 618 600 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-511</sup>
###xml 720 724 706 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-634</sup>
###xml 251 256 <span type="species:ncbi:9606">women</span>
###xml 1047 1052 <span type="species:ncbi:9606">women</span>
The aims of this study were to investigate the relationships between the production of interleukin-1 (IL-1), and IL-6 system by whole blood cells, and bone mineral density (BMD), and polymorphisms in IL-1 system and IL-6 gene in postmenopausal Korean women. The production of IL-1alpha, IL-1beta, IL-1 receptor antagonist (IL-1ra), IL-6, and soluble IL-6 receptor (sIL-6r) by lipopolysaccharide-stimulated whole blood cells was measured by ELISA in 110 subjects. Serum osteocalcin, C-telopeptide of type I collagen, and BMD at lumbar spine and proximal femur were measured. IL-1alphaC-889T polymorphism, IL-1beta C-511T polymorphism, 86-base pair variable number tandem repeat polymorphism in the IL-1ra gene, and IL-6 C-634G polymorphism were analyzed. The production of IL-1beta correlated positively with BMD at femoral neck, whereas the production of other ILs did not correlate with BMD at the skeletal sites examined. No significant differences in the production of ILs were observed among normal, osteopenic and osteoporotic postmenopausal women, and among the different IL system polymorphisms groups studied. No correlation between bone turnover markers and the production of ILs was noted. In conclusion IL-1beta may regulate bone metabolism at femoral neck, and the IL system polymorphism do not affect the production of ILs by whole blood cells.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 591 592 584 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 958 959 951 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 960 961 953 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1248 1250 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1267 1269 1260 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 105 111 <span type="species:ncbi:9606">person</span>
###xml 1377 1382 <span type="species:ncbi:9606">women</span>
###xml 1406 1411 <span type="species:ncbi:9606">women</span>
Osteoporosis is defined as a skeletal disorder characterized by compromised bone strength predisposing a person to an increased risk of fracture (1). Bone mass accounts for approximately 70% of bone strength. At menopause, an uncoupling of bone remodeling, in which bone resorption exceeds bone formation, results in progressive bone loss and postmenopausal osteoporosis. It has been supposed that both the interleukin (IL) -1 family of cytokines and the IL-6 system may be involved in bone remodeling. IL-1alpha, IL-1beta, and IL-6 are believed to be potent stimulators of bone resorption (2). Cytokine activity depends on the balance with natural modulators. IL-1 receptor antagonist (IL-1ra) is a competitive inhibitor of IL-1, and soluble IL-6 receptor (sIL-6r) acts as an agonist of IL-6. However, clinical studies on the possibility of involvement of these cytokines in the development of postmenopausal osteoporosis have led to contradictory results (3-9). Some of the conflict in results may be due to the differences in methodology of sample collections. A lot of advantages of whole blood cell culture in measuring cytokine secretion have recently been demonstrated, compared with serum measurement, or peripheral blood monocyte culture (10). Zheng et al. (11) reported that IL-1beta and IL-6 production by whole blood cells was higher in osteoporotic postmenopausal women than in normal healthy women, but they did not adjust IL-1beta production to total cell counts, and did not measure the level of IL-1alpha, IL-1ra, and sIL-6r. The balance between IL-1 and IL-1ra, and that between IL-6 and soluble IL-6 receptor are important to understand a whole picture of these IL systems' effects.
###end p 3
###begin p 4
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 384 388 384 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-889</sup>
###xml 426 428 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 436 440 432 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-511</sup>
###xml 496 498 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 592 594 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 605 609 598 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-634</sup>
###xml 661 663 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 327 332 <span type="species:ncbi:9606">human</span>
###xml 1023 1028 <span type="species:ncbi:9606">women</span>
We have recently demonstrated that the cytosine-adenine (CA) polymorphism in the insulin-like growth factor-I (IGF-I) gene is associated with serum IGF-I levels (12). Similarly, polymorphisms within the cytokine genes may be genetic basis for the cytokine production by whole blood cells. Recently, a number of polymorphism in human IL-1 system and IL-6 gene have been reported: the C-889T polymorphism in the IL-1alpha gene (13), the C-511T polymorphism in the promoter region of IL-1beta gene (14), the 86 base pair (bp) variable number tandem repeat (VNTR) in intron 2 of the IL-1ra gene (15) and the C-634G polymorphism in the promoter region of IL-6 gene (16) etc. The significance of these polymorphisms in terms of protein production by whole blood cells has not yet been determined. The aims of the present study were to investigate the relationship between the production of IL-1alpha, IL-1beta??IL-1ra, IL-6, and soluble IL-6 receptor by whole blood cells, and bone mineral density (BMD) in postmenopausal Korean women and to evaluate whether IL system gene polymorphisms affect the production of ILs by whole blood cells.
###end p 4
###begin title 5
MATERIALS AND METHODS
###end title 5
###begin title 6
Study subjects
###end title 6
###begin p 7
###xml 39 44 <span type="species:ncbi:9606">women</span>
###xml 442 447 <span type="species:ncbi:9606">Women</span>
###xml 492 497 <span type="species:ncbi:9606">women</span>
This study included 110 postmenopausal women, between the ages of 48 and 65 yr, who visited the Menopause Clinic of Seoul National University Hospital for bone mass examination, and who agreed to participate in the study. All of the subjects had been without spontaneous menses for at least one year. They underwent a careful physical examination, and a medical history review. Blood glucose, and hepatic and renal functions were determined. Women who had undergone bilateral oophorectomy or women with current hepatic disease, renal disease or diabetes mellitus were excluded. None of the subjects had received any medication known to affect bone metabolism before the study. All subjects gave their informed consent, and the study protocol was approved by the Institutional Review Board of Seoul National University Hospital.
###end p 7
###begin title 8
Measurements of BMD and body mass index (BMI)
###end title 8
###begin p 9
###xml 70 71 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 73 74 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 666 667 666 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 430 435 <span type="species:ncbi:9606">women</span>
BMD was measured in grams per square centimeter at the lumbar spine (L2-L4), femoral neck, trochanter, and Ward's triangle, using a Lunar DPX-L dual-energy radiography absorptiometer (Lunar Radiation Corp., Madison, WI, U.S.A.), and categorized into three groups according to the World Health Organization's criteria (17) as, normal, osteopenic, or osteoporotic, relative to the means and standard deviation of young adult Korean women. The in vivo coefficient of variation was 1.4% for the lumbar spine, 2.1% for the femoral neck, 1.1% for the trochanter, and 2.1% for Ward's triangle. BMI was calculated by dividing body weight (kg) by the square of body height (m2).
###end p 9
###begin title 10
Whole blood cells cultures
###end title 10
###begin p 11
###xml 657 658 645 646 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 721 722 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Blood samples were collected, from all subjects in accordance with the guidelines of the Declaration of Helsinki, with endotoxin free vacuum blood collection tubes containing preservative free heparin, and total number of monocytes and lymphocytes were counted. Blood was diluted 1/10 in RPMI (Gibco, Grand Island, NY, U.S.A.) complemented with 2 mM glutamine, 100 U/mL penicillin, 100 microg/mL streptomycin, 0.25 microg/mL amphotericin B and transferred into Falcon culture tubes with or without lipopolysaccharide (LPS) (Sigma, St Louis, MO, U.S.A.) at a final concentration of 25 microg/mL. Culture tubes were then incubated for 2 days at 37℃ in a 5% CO2 atmosphere. After incubation, samples were centrifuged at 800xg for 10 min, supernatants were collected, and frozen at -20℃ until assay for ILs.
###end p 11
###begin title 12
Measurements of IL-1alpha, IL-1beta, IL-1ra, IL-6, and sIL-6r in culture supernatant
###end title 12
###begin p 13
###xml 1140 1141 1119 1120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
IL-1alpha, and IL-1ra were measured using a quantitative sandwich immunoassay kit purchased from R & D systems (Minneapolis, MN, U.S.A.). The minimum detection limit was 1 pg/mL for IL-1alpha, and 14 pg/mL for IL-1ra. Intra- and interassay variations for IL-1alpha were 3.8% and 5.2%, respectively. Intra- and inter-assay variations for IL-1ra were 4.0% and 5.1%, respectively. IL-1beta and IL-6 were measured using an enzyme linked immunosorbent assay kit purchased from Chemicon International Inc. (Temecula, CA, U.S.A.). The minimum detection limit was 0.195 ng/mL for IL-1beta and IL-6. Intra- and inter-assay variations for IL-1beta were 8.1% and 11.7%, respectively. Intra- and inter-assay variations for IL-6 were 7.0% and 11.3%, respectively. sIL-6r was measured using an enzyme linked immunosorbent assay kit purchased from Bender MedSystems (Vienna, Austria). The minimum detection limit was 0.02 ng/mL for sIL-6r. Intra- and interassay variations for sIL-6r were 1.7% and 2.2%, respectively. The resulting IL levels were then corrected for total monocyte and lymphocyte cell numbers. The values given are quoted in ng or pg/mL/106 cells.
###end p 13
###begin title 14
Measurements of serum bone turnover markers
###end title 14
###begin p 15
Serum osteocalcin (OST) was measured using a competitive radioimmunoassay kit (Techno Genetics, Milano, Italy), with a minimum detection limit of 0.1 nM/L. The intra- and inter-assay variations for OST were 4.0% and 5.1%, respectively. Serum carboxy-terminal C-telopeptide of type I collagen (CrossLaps; CTX) was measured using a serum CTX one step enzyme-linked immunosorbent assay kit (Osteometer Biotech, Herlev, Denmark), with a minimum detection limit of 94 pM/L, and intra- and inter-assay variations were 5.4% and 5.1%, respectively.
###end p 15
###begin title 16
Determination of the IL-1 system and IL-6 gene polymorphisms
###end title 16
###begin p 17
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 395 398 395 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ava</italic>
###xml 439 443 439 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-511</sup>
###xml 590 592 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 610 613 607 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nco</italic>
###xml 651 655 648 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-889</sup>
###xml 826 828 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 846 849 839 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsr</italic>
###xml 888 892 881 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-634</sup>
###xml 1004 1006 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1131 1134 1124 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ava</italic>
###xml 1137 1140 1130 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nco</italic>
###xml 1147 1150 1140 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsr</italic>
Genomic DNA was extracted from peripheral blood leukocytes using a QiaAmp blood kit (Qiagen GmbH, Hilden, Germany). The 86 bp VNTR polymorphism of the IL-1ra was analyzed as previously described (14, 15). A1 allele (four repeats) was 410 bp, A2 allele (two repeats) 240 bp, A3 allele (five repeats) 495 bp, and A4 allele (three repeats) 325 bp. The 304 bp fragment of genomic DNA containing the AvaI polymorphic portion at position -511 (C-511T) relative to the start site of transcription of the IL-1beta gene was amplified by polymerase chain reaction (PCR), as described by Chen et al. (14). To analyze the NcoI polymorphic site at position -889 (C-889T) of the IL-1alpha gene, the 99 base fragment was amplified by PCR using the same oligonucleotide primers and PCR reaction steps previously described by McDowell et al. (13). To analyze the BsrBI polymorphic site at position -634 (C-634G) in the promoter of the IL-6 gene, PCR amplifications were carried out as described previously by Ota et al. (16). After PCR products were digested with restriction enzymes, the digests were separated on agarose gels. The absence of the AvaI, NcoI, and BsrBI sites was designated as the A, N, and B allele, respectively, and the presence of these restriction cutting sites was designated as a, n, and b allele, respectively.
###end p 17
###begin title 18
Statistical analysis
###end title 18
###begin p 19
###xml 246 247 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 937 938 933 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
All data are expressed as the mean+/-SE. Statistical analysis was performed using the SAS statistical program (SAS Institute, Cary, NC, U.S.A.). The genotype frequencies for each polymorphism against Hardy-Weinberg ratios were assessed by the chi2-test or Fisher's exact test. Differences in anthropometric characteristics between the different IL genotypes were tested using one way analysis of variance (ANOVA) followed by Tukey's test, or using Student's t-test. Similar comparisons were made for BMD, the serum levels of bone turnover markers, or for the production of ILs by whole blood cells using Student's t-test, or after adjusting potential confounding factors, such as age, and years since menopause, by analysis of covariance (ANCOVA). To assess the relationship between the production of ILs by whole blood cells and BMD, simple regression analysis was performed and Pearson's correlation coefficient was then calculated. A p value of less than 0.05 was considered significant for all analyses.
###end p 19
###begin title 20
RESULTS
###end title 20
###begin p 21
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 812 813 792 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 968 975 942 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 156 161 <span type="species:ncbi:9606">women</span>
###xml 633 638 <span type="species:ncbi:9606">women</span>
Table 1 shows the cytokine production by whole blood cells and serum levels of bone turnover markers in normal, osteopenic, and osteoporotic postmenopausal women. LPS treatment induced an increase in the production of IL-1alpha, IL-1beta, IL-6, and sIL-6r by whole blood cells and an increased IL-1beta/IL-1ra ratio. After adjusting for potential confounding factors, such as age, and years since menopause, no significant differences were observed in the basal production of IL-1alpha, IL-1beta, IL-1ra, IL-6, or sIL-6r by whole blood cells, or in the IL-1beta/IL-1ra ratio among normal, osteopenic, and osteoporotic postmenopausal women and this trend persisted even in the LPS stimulation. The production of IL-1 by LPS-stimulated whole blood cells correlated positively with BMD at the femoral neck (r=0.16, p<0.05), whereas the production of IL-1beta, IL-1ra, IL-6, sIL-6r, and the IL-1beta/IL-1ra ratio did not correlate with BMD at the skeletal sites examined (Table 2). There were no significant correlations between IL system components and bone turnover markers such as osteocalcin and CTX.
###end p 21
###begin p 22
###xml 332 335 328 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nco</italic>
###xml 347 350 340 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ava</italic>
###xml 362 365 355 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsr</italic>
###xml 592 599 585 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 893 900 869 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
Four alleles in the IL-1ra VNTR polymorphism were observed: A1 96.4%; A2 1.8%; A3 1.4%; A4 0.4%. When study subjects were grouped according to carriage of the A2 allele, two genotypes were noted: the heterozygotes, A1A2, A3A2, (3.6%) and the noncarriage group, i.e., A1A1, A1A4, and A3A3 (96.4%). The distributions of the IL-1alpha NcoI, IL-1beta AvaI, and IL-6 BsrBI polymorphisms were as follows; nn 85.5%, Nn 13.6%, NN 0.9%, aa 35.5%, Aa 50.9%, AA 13.6%, bb 6.4%, Bb 34.5%, and BB 59.1% respectively. These IL system allele frequencies followed the Hardy-Weinberg equilibrium. As shown in Table 3, regardless of LPS stimulation, the production of IL-1alpha, IL-1beta, IL-1ra, IL-6, or sIL-6r by WBCs and the IL-1beta/IL-1ra ratio were not different according to IL-1alpha, IL-1beta or IL-1ra genotypes. IL-6 genotypes did not affect the production of IL-6, and sIL-6r by whole blood cells (Table 4).
###end p 22
###begin title 23
DISCUSSION
###end title 23
###begin p 24
###xml 503 506 492 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nco</italic>
###xml 518 521 504 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ava</italic>
###xml 540 543 526 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsr</italic>
###xml 325 330 <span type="species:ncbi:9606">women</span>
A central role of immune system has been suggested in bone remodeling through proinflammatory cytokines. In the present study, we investigated the relationships among the production of interleukin-1 and IL-6 system by whole blood cells, and bone mass, and polymorphisms in IL-1 system and IL-6 genes in postmenopausal Korean women. To the best of our knowledge, this is the first report of its kind that have comprehensively analyzed about IL-1alpha, IL-1beta, IL-1ra, IL-6, sIL-6r levels and IL-1alpha NcoI, IL-1beta AvaI, IL-1ra A2, IL-6 BsrBI polymorphism.
###end p 24
###begin p 25
###xml 204 205 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 217 218 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 284 285 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 286 287 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 428 429 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 430 431 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 458 460 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1102 1104 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1458 1460 1428 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1649 1651 1619 1621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 325 330 <span type="species:ncbi:9606">women</span>
###xml 357 362 <span type="species:ncbi:9606">women</span>
###xml 587 592 <span type="species:ncbi:9606">women</span>
###xml 623 628 <span type="species:ncbi:9606">women</span>
###xml 936 941 <span type="species:ncbi:9606">women</span>
###xml 968 973 <span type="species:ncbi:9606">women</span>
It has been suggested that IL system may be implicated in the pathogenesis of postmenopausal osteoporosis. However, no differences has been noted in the circulating levels of IL-1alpha, IL-1beta, IL-1ra (3), or IL-6 (4) or in the production of IL-1beta by peripheral blood monocytes (5-6) between osteoporotic postmenopausal women and normal postmenopausal women, although some researchers have reported contradictory findings (7-9). Recently, Zheng et al. (11) reported that IL-1beta and IL-6 production by mitogen-stimulated whole blood cells was higher in osteoporotic postmenopausal women than in normal postmenopausal women, and that lumbar BMD correlated negatively with IL-1beta production. In the present study, regardless of LPS stimulation, we were unable to find any differences in the production of IL-1alpha, IL-1beta, or IL-1ra, IL-6 or sIL-6r by WBCs, or in the IL-1beta/IL-1ra ratios between osteoporotic postmenopausal women and normal postmenopausal women. A number of possible reasons may be proposed to explain the discrepancy of results between our study and that of Zheng et al. (11). First, they did not adjust the measured IL levels to total cell counts, whereas we did. Second, the whole blood cells culture time is relatively shorter in their study (1 day) than in our study (2 days), and it has been reported that the production of IL-1alpha and IL-2 reaches a maximum around 2-4 days after the start of whole blood cells culture (10). Third, they used both phytohemagglutinin and LPS, whereas we used LPS only. Finally, the number of study subjects in our study was twice as many as that from the report by Zheng et al. (11).
###end p 25
###begin p 26
###xml 422 424 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
In the present study, IL-1beta production by LPS-stimulated whole blood cells correlated positively with BMD of femoral neck. This finding suggests that high IL-1 does not always have a resorptive effect on all skeletal mass. This hypothesis is supported by recent findings that high cytokine production by peripheral blood monocytes is related with greater BMD gain in femoral neck, but greater bone loss in spinal bone (18). This possible site-specific skeletal effect of a certain cytokine needs to be elucidated by further studies.
###end p 26
###begin p 27
###xml 194 196 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 329 331 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 333 335 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 364 367 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsr</italic>
###xml 451 453 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 645 647 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 444 449 <span type="species:ncbi:9606">women</span>
Genotype frequencies of the IL-1 system genes in our subjects differ from those reported in Caucasians. The aa genotype of the IL-1beta gene is less common than in Caucasians (35.5% vs. 43.4%) (19), and the NN the genotype of the IL-1alpha gene and A2 allele of the IL-1ra gene in Koreans were very rare, compared to Caucasians (13, 15). The distributions of IL-6 BsrBI genotypes in Koreans are similar to those previously reported in Japanese women (20). No differences were found in the production of IL-1alpha, IL-1beta, or IL-1ra by whole blood cells, or the IL-1beta/IL-1ra ratios among IL-1 system genotypes, although other investigators (18) have reported that the presence of the IL-1ra A2 allele is associated with an enhanced IL-1beta and IL-1ra production, and a reduced IL-1alpha production by peripheral blood monocytes. These discrepancies may be due to differences in methodology of sample collection. In addition, there was no association of IL-6 genotypes with the production of IL-6 and sIL-6r in the present study.
###end p 27
###begin p 28
Three types of sampling methods have been used to measure cytokine secretion; serum measurement, peripheral blood monocyte culture and whole blood cells culture. Of these methods, whole blood cells culture does not disturb the concentrations of circulating factors and the ratios of different cells, which may be important for normal molecular and intracellular interactions. Moreover, it has the advantage of being much quicker and simpler than peripheral blood monocyte culture, and is less likely to result in the contamination of samples.
###end p 28
###begin p 29
In conclusion, IL-1beta may regulate bone metabolism at femoral neck and IL polymorphisms do not affect the production of ILs by whole blood cells. Systemic ILs production by whole blood cells may not reflect the status of the cytokine production in the bone microenvironment. And thus, further cross-sectional and longitudinal studies are needed on the relationship between bone mass and cytokine production in the microenvironment of bone marrow.
###end p 29
###begin p 30
###xml 28 115 28 115 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a grant of Korea Health 21 R&amp;D Project, Ministry of Health &amp; Welfare, Republic of Korea</funding-source>
###xml 118 139 118 139 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">02-PJ1-PG3-21001-0005</award-id>
This study was supported by a grant of Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (#02-PJ1-PG3-21001-0005).
###end p 30
###begin article-title 31
Osteoporosis prevention, diagnosis, and therapy
###end article-title 31
###begin article-title 32
Cytokines in the pathogenesis of osteoporosis
###end article-title 32
###begin article-title 33
###xml 55 60 <span type="species:ncbi:9606">women</span>
Circulating cytokine levels in osteoporotic and normal women
###end article-title 33
###begin article-title 34
Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes
###end article-title 34
###begin article-title 35
Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis
###end article-title 35
###begin article-title 36
Cytokine production by peripheral blood cells in postmenopausal osteoporosis
###end article-title 36
###begin article-title 37
###xml 42 47 <span type="species:ncbi:9606">human</span>
Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis
###end article-title 37
###begin article-title 38
###xml 127 132 <span type="species:ncbi:9606">women</span>
The relationship between interleukin-1 receptor antagonist gene polymorphism and bone mineral density in postmenopausal Korean women
###end article-title 38
###begin article-title 39
###xml 99 104 <span type="species:ncbi:9606">women</span>
Cytokine production and bone mineral density at the lumbar spine and femoral neck in premenopausal women
###end article-title 39
###begin article-title 40
###xml 65 70 <span type="species:ncbi:9606">human</span>
Evaluation of a test system for measuring cytokine production in human whole blood cell cultures
###end article-title 40
###begin article-title 41
Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis
###end article-title 41
###begin article-title 42
###xml 149 154 <span type="species:ncbi:9606">women</span>
The relationship among serum insulin-like growth factor-I, insulin-like growth factor-I gene polymorphism and bone mineral density in postmenopausal women in Korea
###end article-title 42
###begin article-title 43
A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism
###end article-title 43
###begin article-title 44
###xml 92 97 <span type="species:ncbi:9606">women</span>
Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphism in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis
###end article-title 44
###begin article-title 45
###xml 16 21 <span type="species:ncbi:9606">human</span>
Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat
###end article-title 45
###begin article-title 46
A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density
###end article-title 46
###begin article-title 47
The diagnosis of osteoporosis
###end article-title 47
###begin article-title 48
Presence of the IL-1RA allele (IL1RN*2) is associated with enhanced IL-1 beta production in vitro
###end article-title 48
###begin article-title 49
Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene
###end article-title 49
###begin article-title 50
###xml 172 177 <span type="species:ncbi:9606">women</span>
###xml 182 185 <span type="species:ncbi:9606">men</span>
Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men
###end article-title 50
###begin p 51
###xml 140 145 <span type="species:ncbi:9606">women</span>
Cytokine production from whole blood cells and serum levels of bone turnover markers in normal, osteopenic, and osteoporotic postmenopausal women
###end p 51
###begin p 52
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*Values are adjusted for age, years since menopause and expressed as mean+/-SE.
###end p 52
###begin p 53
BMI, body mass index; IL, Interleukin; IL-1ra, IL-1 receptor antagonist; sIL-6r, soluble IL-6 receptor; CTX, CrossLaps.
###end p 53
###begin p 54
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 11 44 11 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;,&#8225;,&#167;</sup>
###xml 46 47 18 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 54 62 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8741;</sup>
###xml 64 65 29 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 72 89 37 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#182;,**</sup>
###xml 91 92 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 100 139 52 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;&#8224;,&#8225;&#8225;</sup>
###xml 141 142 59 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p, ANCOVA; dagger,double dagger,section sign, p<0.01; parallel, p<0.05; paragraph sign,**, p<0.001; daggerdagger,double daggerdouble dagger, p<0.05 (by Tukey's test).
###end p 54
###begin p 55
Correlation coefficients between bone mineral density, bone turnover markers and cytokine production from lipopolysaccharide-stimulated whole blood cells (n=110)
###end p 55
###begin p 56
###xml 82 83 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
IL, interleukin; IL-1ra, IL-1 receptor antagonist; sIL-6r, soluble IL-6 receptor. *, p<0.05.
###end p 56
###begin p 57
###xml 68 71 64 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nco</italic>
###xml 83 86 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ava</italic>
Cytokine production from whole blood cells in relation to IL-1alpha NcoI, IL-1beta AvaI, and IL-1ra polymorphism
###end p 57
###begin p 58
Values are adjusted for age, and years since menopause, and expressed as mean+/-SE.
###end p 58
###begin p 59
IL- 1ra, IL-1 receptor antagonist; sIL-6r, soluble IL-6 receptor; IL-1ra A2 negative: A1A1, A1A4, A3A3; IL-1ra A2 positive: A1A2, A3A2.
###end p 59
###begin p 60
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsr</italic>
Cytokine production from whole blood cells in relation to IL-6 BsrBI polymorphism
###end p 60
###begin p 61
Values are adjusted for age, years since menopause, and expressed as mean+/-SE.
###end p 61
###begin p 62
###xml 67 68 67 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
IL- 1ra, IL-1 receptor anatagonist; sIL-6r, soluble IL-6 receptor; p, ANOVA.
###end p 62

